# Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

> **NCT05207358** · PHASE4 · RECRUITING · sponsor: **Institutul Clinic Fundeni** · enrollment: 30 (estimated)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Cyclophosphamide
- **DRUG:** Corticosteroids

## Key facts

- **NCT ID:** NCT05207358
- **Lead sponsor:** Institutul Clinic Fundeni
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-02
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05207358

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05207358, "Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05207358. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*